258 related articles for article (PubMed ID: 26234674)
21. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
22. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
[TBL] [Abstract][Full Text] [Related]
23. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
Lyu H; Wang S; Huang J; Wang B; He Z; Liu B
Cancer Lett; 2018 Apr; 420():97-108. PubMed ID: 29409974
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
Zhang X; Zhang Y; Liu X; Fang A; Li P; Li Z; Liu T; Yang Y; Du L; Wang C
PLoS One; 2015; 10(11):e0143441. PubMed ID: 26599571
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050
[TBL] [Abstract][Full Text] [Related]
27. The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells.
Pink RC; Samuel P; Massa D; Caley DP; Brooks SA; Carter DR
Gynecol Oncol; 2015 Apr; 137(1):143-51. PubMed ID: 25579119
[TBL] [Abstract][Full Text] [Related]
28. miR-200a-3p promotes the proliferation of human esophageal cancer cells by post-transcriptionally regulating cytoplasmic collapsin response mediator protein-1.
Zang Y; Tai Y; Wan B; Jia X
Int J Mol Med; 2016 Nov; 38(5):1558-1564. PubMed ID: 28025999
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis.
Chen W; Zeng W; Li X; Xiong W; Zhang M; Huang Y; Zhou L; Jiang S
Pharmacogenomics; 2016 Feb; 17(3):187-97. PubMed ID: 26786897
[TBL] [Abstract][Full Text] [Related]
30. MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells.
Phatak P; Burrows WM; Creed TM; Youssef M; Lee G; Donahue JM
BMC Cancer; 2022 Dec; 22(1):1265. PubMed ID: 36471277
[TBL] [Abstract][Full Text] [Related]
31. Induction of growth arrest by miR-542-3p that targets survivin.
Yoon S; Choi YC; Lee S; Jeong Y; Yoon J; Baek K
FEBS Lett; 2010 Sep; 584(18):4048-52. PubMed ID: 20728447
[TBL] [Abstract][Full Text] [Related]
32. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
[TBL] [Abstract][Full Text] [Related]
33. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
[TBL] [Abstract][Full Text] [Related]
34. miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.
Wang F; Xia J; Wang N; Zong H
Onkologie; 2013; 36(12):754-8. PubMed ID: 24356567
[TBL] [Abstract][Full Text] [Related]
35. Effect miR-214-3p on proliferation and apoptosis of breast cancer cells by targeting survivin protein.
Han LC; Wang H; Niu FL; Yan JY; Cai HF
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7469-7474. PubMed ID: 31539134
[TBL] [Abstract][Full Text] [Related]
36. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.
Zhang F; Yang Z; Cao M; Xu Y; Li J; Chen X; Gao Z; Xin J; Zhou S; Zhou Z; Yang Y; Sheng W; Zeng Y
Cancer Lett; 2014 Jan; 342(1):121-9. PubMed ID: 24001611
[TBL] [Abstract][Full Text] [Related]
37. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.
Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273
[TBL] [Abstract][Full Text] [Related]
38. Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Wang Y; Fang Q; Tian L; Yuan Z; Tian L; Zhou Z
Technol Cancer Res Treat; 2020; 19():1533033820920967. PubMed ID: 32356485
[TBL] [Abstract][Full Text] [Related]
39. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
40. miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2.
Xu ZH; Yao TZ; Liu W
Biomed Pharmacother; 2018 Nov; 107():1410-1417. PubMed ID: 30257357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]